Description

n-(6-Bromoimidazo[1,2-A]Pyridin-2-Yl)-2,2,2-Trifluoroacetamide CAS NO 504413-35-8 is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure containing bromine and trifluoroacetamide functional groups. This compound is of significant value for its role as a key building block in the synthesis of complex bioactive molecules, particularly in medicinal chemistry. It is primarily needed by research institutions and pharmaceutical companies engaged in the development of new drug candidates, especially those targeting neurological disorders and oncology.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for drug discovery programs.
• Bioconjugation & Probe Development: The reactive bromo and amide groups make it suitable for creating chemical probes and bioconjugates for biological studies.
• Agrochemical Synthesis: Potential use as an intermediate in the development of new crop protection agents and pesticides.
• Material Science: Can be utilized in the synthesis of specialized organic electronic materials or ligands for catalysis.

Basic Information

Product Name	n-(6-Bromoimidazo[1,2-A]Pyridin-2-Yl)-2,2,2-Trifluoroacetamide
CAS No.	504413-35-8
Molecular Formula	C9H5BrF3N3O
Molecular Weight	308.06 g/mol
Synonyms	2,2,2-Trifluoro-N-(6-bromoimidazo[1,2-a]pyridin-2-yl)acetamide; 6-Bromo-2-(2,2,2-trifluoroacetamido)imidazo[1,2-a]pyridine; N-(6-Bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide; 504413-35-8; 6-Bromo-2-trifluoroacetamidoimidazo[1,2-a]pyridine; 2-Acetamide, N-(6-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoro-; Trifluoroacetamide, N-(6-bromoimidazo[1,2-a]pyridin-2-yl)-
EINECS	Contact for details

Quality Control

Our n-(6-Bromoimidazo[1,2-A]Pyridin-2-Yl)-2,2,2-Trifluoroacetamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical R&D. Comprehensive Certificates of Analysis (COA) detailing purity (typically ≥95% to ≥98% by HPLC), identity confirmation, and impurity profiles are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storage under inert atmosphere to ensure maximum stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.